Call toll-free 800.328.1267
Market Insights has covered the split between the new winners and losers in technology. Something similar seems to be underway in the health-care sector. Drug makers whose products offer the promise of growth have led. These includes biotechnology stocks, which keep...
Last week was a lot more interesting than it seemed. After all, the S&P 500 rose just 0.6 percent in the holiday-shortened week between Friday, February 15 and Friday, February 22. Most other major indexes hardly budged, either. But there was disruption beneath...
Unusual companies advanced following their quarterly results in the last week, continuing a trend this earnings season. Consider Garmin (GRMN) and Arista Networks (ANET), the two biggest gainers in the S&P 500 since our last review. GRMN, a one-time leader in GPS...
The last week of quarterly results featured bad news from some high-profile stocks, but other names rose in prominence. Right off the bat, Apple (AAPL) had disappointing iPhone sales and stunned investors by saying it would stop reporting unit volumes on its flagship...
News reports have seen it coming for months, but now it's official: Amazon.com (AMZN) is attacking drug distributors. AMZN announced the purchase of closely held PillPack. The smaller company caters to patients who routinely take large numbers of medicines, like for...